COVID-19 Vaccine Information

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

Centers for Disease Control and Prevention COVID-19 Vaccine Information
Arizona Department of Health Services COVID-19 Vaccine Information
Navajo Nation COVID-19 Vaccine Information

Click here for Vaccination Locations
Coconino County COVID-19 Information Line: 928-679-7300

Vaccine Information

Vaccine for Children Ages 5-11

The Centers for Disease Control and Prevention (CDC) approved the Pfizer (Comirnaty) vaccine for children ages 5-17 years, at a lower dosage. Coconino County Health and Human Services is administering the lower dosage Pfizer vaccine to children ages 5-17. Additionally, several healthcare providers and pharmacies also offer COVID-19 vaccinations. Please contact them directly for the most current information. COVID-19 vaccines are provided at no cost. Click here for COVID-19 vaccination locations.

Booster Doses  

COVID-19 boosters help broaden and strengthen protection against COVID-19 and its variants. 

The Pfizer COVID-19 booster dose is authorized and recommended for adolescents aged 12 and older administered at least 5 months post their initial Pfizer vaccination series. Adults are recommended to receive a booster dose at least 5 months after receiving the Pfizer or Moderna series and 2 months after for the Johnson and Johnson series.

New CDC guidance allows adults 18+ to choose which type of vaccine booster they receive, allowing for mixing and matching of vaccines, subject to that vaccine’s timing and eligibility recommendations for booster doses. 

Additional Booster Doses  

People over the age of 50 and certain immunocompromised individuals who received an initial booster dose at least 4 months ago are now eligible for another mRNA booster to increase their protection against severe disease from COVID-19. Adults who received a primary vaccine and booster dose of Johnson & Johnson’s COVID-19 vaccine at least 4 months ago may now receive an additional booster dose using an mRNA COVID-19 vaccine. For more information.

  • People ages 12 years and older who are moderately or severely immunocompromised may choose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster dose.
  • Adults ages 50 years and older who are not moderately or severely immunocompromised may choose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster dose.
  • People ages 18–49 years who are not moderately or severely immunocompromised and who received Johnson & Johnson COVID-19 Vaccine as both their primary series dose and booster dose may receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first Janssen booster dose.

Click here for a booster information chart.

Immunocompromised Individuals

The Centers for Disease Control and Prevention recommends an additional COVID-19 vaccine dose for certain immunocompromised individuals. Click here for more information. 

Vaccine Schedule

Children 5-17 years

  • Pfizer (Comrinaty) Vaccine
    • The 2nd dose should be scheduled at least 21 days following first dose.

Adult

  • Pfizer (Comirnaty) Vaccine
    • The 2nd dose should be scheduled at least 21 days following the first dose.
    • A booster dose should be scheduled at least 5 months following the completion of the initial 2 dose series.
  • Moderna
    • The 2nd dose should be scheduled at least 28 days following the first dose.
    • A booster dose should be scheduled at least 5 months following the completion of the initial 2 dose series.
  • Johnson & Johnson Vaccine
    • Booster recommended at least 2 months following initial vaccination series.
  • An 8-week interval between dose 1 and dose 2 of a primary mRNA COVID-19 vaccine schedule may benefit some people ages 12 through 64 years, and particularly males ages 12 through 39 years. Please discuss the recommended interval between dose 1 and dose 2 with your healthcare provider or vaccination site staff. COVID-19 vaccination guidance is continually evolving. Please check with your provider for the most current recommendations.